Ryan Bartolucci Net Worth

Ryan Bartolucci biography

Ryan Bartolucci is Vice President - Finance, Corporate Controller of the Company. He joined RTI Surgical in September 2018 as Vice President, Finance and Corporate Controller. Prior to joining the Company, Mr. Bartolucci, was employed with Sagent Pharmaceuticals, a generic injectable company, from August 2015 to September 2018. Mr. Bartolucci started his career at PricewaterhouseCoopers LLP, where, during his eleven years at the firm, he served in various assurance roles. A certified public accountant, Mr. Bartolucci joins as a proven leader of talented accounting professionals, with strong acumen in technical accounting, financial reporting and compliance and controls.

How old is Ryan Bartolucci?

Ryan Bartolucci is 37, he's been the Vice President - Finance e Corporate Controller of RTI Surgical since 2018. There are 10 older and no younger executives at RTI Surgical. The oldest executive at RTI Surgical Holdings, Inc. is Thomas McEachin, 67, who is the Independent Director.

What's Ryan Bartolucci's mailing address?

Ryan's mailing address filed with the SEC is 520 LAKE COOK ROAD, SUITE 315, DEERFIELD, IL, 60015.

Insiders trading at RTI Surgical

Over the last 21 years, insiders at RTI Surgical have traded over $71,830 worth of RTI Surgical stock and bought 390,515 units worth $1,973,594 . The most active insiders traders include Jeffrey C Lightcap, Mark Stolper e Terry M. Rich. On average, RTI Surgical executives and independent directors trade stock every 138 days with the average trade being worth of $62,561. The most recent stock trade was executed by Jonathon M Singer on 12 December 2018, trading 50,000 units of RTIX stock currently worth $214,000.

What does RTI Surgical do?

RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.

RTI Surgical executives and stock owners

RTI Surgical executives and other stock owners filed with the SEC include:

• Jonathon Singer,
  Chief Financial Officer, Chief Operating Officer
• John Varela,
  Executive Vice President - Global Operations
• Olivier Visa,
  Vice President - OEM, Sports and Donor Services
• Shirley Weis,
  Independent Director
• Thomas McEachin,
  Independent Director
• Mark Stolper,
  Lead Independent Director
• Paul Thomas,
  Independent Director
• Nicholas Valeriani,
  Independent Director
• Pawel Lewicki,
  Director
• Scott Durall,
  Chief Commercial Officer
• Bryan Cornwall,
  Executive Vice President - Research and Clinical Affairs
• Stuart Simpson,
  Chairman of the Board
• Molly Poarch,
  Director, Corporate Communications & Investor Relations
• Jeffrey Lightcap,
  Independent Director
• Brian Kushner,
  Director
• Ryan Bartolucci,
  Vice President - Finance, Corporate Controller
• Terry Rich,
  President, Chief Executive Officer, Director
• Lyle P. Luedeman,
  
• Dean H Bergy,
  Director
• Street Healthcare Partners ...,
  
• Christopher R Sweeney,
  Director
• Curtis M Selquist,
  Director
• Peter F Gearen,
  Director
• Brian K Hutchison,
  Chairman, President and CEO
• Camille Farhat,
  Chief Executive Officer
• Robert P Jordheim,
  Executive Vice President/CFO
• Roger W Rose,
  Vice President Donor Services
• Johannes Wynand Louw,
  Vice President Finance
• Kevin D Brandt,
  EVP CCO-Domestic Direct
• Joshua H De Rienzis,
  General Counsel
• Philip R Chapman,
  Director
• Ned Hoye Villers,
  Director
• Adrian J R Smith,
  Director
• Caroline A Hartill,
  V.P. Quality Assurance
• Julianne M Bowler,
  Director
• Roy D Crowninshield,
  Director
• Gregory P Rainey,
  Director
• Neal B Freeman,
  Director
• Michael J La Prade,
  Vice President
• Holdings Inc Zimmer,
  10% owner
• Roderick N Allen,
  Vice President
• David J Simpson,
  Director
• Guy L Mayer,
  President
• Michael J Odrich,
  Director
• Lee Robert Jr Johnston,
  Vice President
• Udo Henseler,
  Director
• Christie J Blakely,
  Vice President
• Robert J Lane,
  Vice President
• Tara Leigh Zerby,
  VP, Xenograft Technologies
• Carolyn Shaffer,
  Vice President, Human Resource
• Thomas F Rose,
  Vice President and CFO
• Michael T Manley,
  Director
• Louis E Barnes,
  Vice President-Cardiovascular
• Charles Randal Mills,
  V.P. of Business Development
• William Melendez,
  Vice President, Research & Dev
• Jeffrey Michael Schumm,
  Vice Pres. and General Counsel
• Joseph W Condon,
  Vice President-Operations